A company has started selling the first blood test to help diagnose Alzheimer’s disease, a leap for the field that could make it much easier for people to learn whether they have dementia. It also raises concern about the accuracy and impact of such life-altering news. [Read more…] about Questionable “Alzheimer’s blood test” goes on sale prior to FDA approval
Vascular Health at Age 36 Tied to Brain Health at 70 (Medpage Today):
“A longitudinal study shed light on just how early people may want to start doing something to reduce their dementia risk decades in the future.
Each 1% increase in Framingham vascular risk score at age 36 was associated with 9% higher white matter hyperintensity volume … (however) Vascular risk scores were not linked to beta-amyloid status at any point. [Read more…] about Study challenges the “seductive” amyloid hypothesis of Alzheimer’s disease (AD)